NCT02419001View on ClinicalTrials.gov

A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

Period 1 - Treatment Sequence AB

Period 1: Ceftriaxone 1 g infused IV over 30 minutes only, no SYN-004

DRUG

Period 1 - Treatment Sequence AC

Period 1: Ceftriaxone 1 g infused IV over 30 minutes only, no SYN-004

DRUG

Period 2 - Treatment Sequence AB

Period 2: Ceftriaxone 1 g infused IV over 30 minutes and SYN-004 75 mg

DRUG

Period 2 - Treatment Sequence AC

Period 2: Ceftriaxone 1 g infused IV over 30 minutes and SYN-004 150 mg

Trial Locations (3)

43210

Columbus

Unknown

Edmonton

Montreal

All Listed Sponsors
lead

Theriva Biologics, Inc.

INDUSTRY

NCT02419001 - A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy | Biotech Hunter | Biotech Hunter